SubHero Banner

Marksans Pharma – Recall metformin extended-release (ER)

October 5, 2020 - Marksans announced a voluntary, consumer-level recall of an additional 76 lots of metformin extended release tablets due to the level of N-Nitrosodimethylamine (NDMA), which has been found to be above the allowable Acceptable Daily Intake (ADI) limit established by the FDA.

Download PDF